$CDXS 4 SEC Filings

Filed On	Filing
14 Oct 2026	Form 4: Erbez Georgia, See Remarks Sold 6,335 shares ($8.62K)
14 Oct 2026	Form 4: Moore Alison, Director Sold 6,335 shares ($8.62K)
18 Jun 2026	Form 4: Parker H Stewart, Director Granted 66,350 Stock Option (Right to Buy)
18 Jun 2026	Form 4: Collins Cynthia, Director Granted 66,350 Stock Option (Right to Buy)
18 Jun 2026	Form 4: Richards Christos, Director Granted 66,350 Stock Option (Right to Buy)
18 Jun 2026	Form 4: Smith David V, Director Granted 66,350 Stock Option (Right to Buy)
18 Jun 2026	Form 4: Singhvi Rahul, Director Granted 66,350 Stock Option (Right to Buy)
18 Jun 2026	Form 4: Martinborough Esther, Director Granted 66,350 Stock Option (Right to Buy)
18 Jun 2026	Form 4: Dilly Stephen George, Director Granted 66,350 Stock Option (Right to Buy)
18 Jun 2026	Form 4: De Vre Raymond, Director Granted 66,350 Stock Option (Right to Buy)
11 Jun 2026	Form 4: De Vre Raymond, Director Sold 2,605 shares ($6.17K)
25 Feb 2026	Form 4: Lutz Stefan, Chief Scientific Officer Granted 316,100 Stock Option (Right to Buy) · Sold 5,862 shares ($6.64K)
25 Feb 2026	Form 4: Moore Alison, Director Granted 993,000 Stock Option (Right to Buy)
25 Feb 2026	Form 4: Erbez Georgia, See Remarks Granted 316,100 Stock Option (Right to Buy)
09 Feb 2026	Form 4: Lutz Stefan, Chief Scientific Officer Sold 2,492 shares ($3.26K)
09 Feb 2026	Form 4: Erbez Georgia, See Remarks Sold 3,826 shares ($5K)
09 Feb 2026	Form 4: Moore Alison, Director Sold 3,826 shares ($5K)
08 Jan 2026	Form 4: Lutz Stefan, CSO Sold 4,685 shares ($7.95K)
01 Dec 2025	Form 4: Opaleye Management Inc., 10% owner Acquired 148,318 shares (Open Market Sale) ($258K) · Sold 5,000 shares ($8.71K) · Sold 107,490 shares ($188K) · 1 more
25 Nov 2025	Form 4: Wolf Dennis P, Director Sold 8,952 shares ($14K)

Comments